mhurhangee/ep-ind-claims huggingface dataset:
A bearing device comprising: a rolling bearing including an inner ring having an inner ring raceway surface on an outer circumferential surface thereof, an outer ring having an outer ring raceway surface on an inner circumferential surface thereof, and a plurality of rolling elements that are rollably disposed between the inner ring raceway surface and the outer ring raceway surface, wherein lubricant is enclosed in a bearing space between the outer circumferential surface of the inner ring and the inner circumferential surface of the outer ring; and an attachment member (12, 13) that is disposed adjacently to the rolling bearing, wherein the attachment member (12, 13) has a lubricant reservoir communicating with the bearing space, characterized in that the lubricant reservoir encloses therein wax-containing lubricant that contains lubricating oil and wax and that based on a liquefaction point which is a predetermined temperature within a temperature range of 10°C to 70°C, is changeable between a liquid state at a temperature exceeding the liquefaction point and a semi-solid state at a temperature equal to or lower than the liquefaction point, that the attachment member (12, 13) includes: an outer ring spacer that is disposed in contact with an axial end face of the outer ring; and an inner ring spacer that faces the outer ring spacer and is disposed in contact with an axial end face of the inner ring, that the inner ring spacer is provided with an inner ring spacer-side flange portion extending outward in a radial direction on a bearing-side outer circumferential surface of the inner ring spacer, that the lubricant reservoir is defined by an inner circumferential surface of the outer ring spacer, an axial end face of the inner ring spacer-side flange portion, and the outer circumferential surface of the inner ring spacer, and that a large diameter labyrinth is formed between an outer circumferential surface of the inner ring spacer-side flange portion and an inner circumferential surface of the outer ring spacer and allows the lubricant reservoir to communicate with the bearing space. a rolling bearing including an inner ring having an inner ring raceway surface on an outer circumferential surface thereof, an outer ring having an outer ring raceway surface on an inner circumferential surface thereof, and a plurality of rolling elements that are rollably disposed between the inner ring raceway surface and the outer ring raceway surface, wherein lubricant is enclosed in a bearing space between the outer circumferential surface of the inner ring and the inner circumferential surface of the outer ring; and an attachment member (12, 13) that is disposed adjacently to the rolling bearing, wherein the attachment member (12, 13) has a lubricant reservoir communicating with the bearing space, characterized in an outer ring spacer that is disposed in contact with an axial end face of the outer ring; and an inner ring spacer that faces the outer ring spacer and is disposed in contact with an axial end face of the inner ring,
An apparatus for the treatment of a soft tissue injury including associated inflammation comprising: a thermal scanning arrangement adapted to scan at least a portion of a patient to provide a thermal image or a thermal dataset; a processing arrangement adapted to review the thermal image or the thermal dataset to determine a point or region of thermal anomaly on the patient; a laser treatment device to provide a laser beam, wherein the laser treatment device is adapted to provide laser treatment radiation at a wavelength in the range of 800 nm to 900 nm; and a guidance arrangement comprising an orientable arm attached to the laser treatment device and adapted to guide the laser beam to the point or region of thermal anomaly on the patient as determined by the processing arrangement, to thereby treat the patient. a thermal scanning arrangement adapted to scan at least a portion of a patient to provide a thermal image or a thermal dataset; a processing arrangement adapted to review the thermal image or the thermal dataset to determine a point or region of thermal anomaly on the patient; a laser treatment device to provide a laser beam, wherein the laser treatment device is adapted to provide laser treatment radiation at a wavelength in the range of 800 nm to 900 nm; and a guidance arrangement comprising an orientable arm attached to the laser treatment device and adapted to guide the laser beam to the point or region of thermal anomaly on the patient as determined by the processing arrangement, to thereby treat the patient.
A heat recovery boiler comprising: a flue-gases flowing chamber extending along a longitudinal axis and provided with an inlet and an outlet; a steam circuit fed with water and extending at least in part inside the flue-gases flowing chamber so as to exploit the heat of the flue-gases to generate steam; an inlet diffuser connected to the inlet of the flue-gases flowing chamber wherein flue-gases from a flue-gases source flow in one advancing direction; the heat recovery boiler being characterized by the fact that at least one first wall (22; 19; 20) of the inlet diffuser is provided with at least one first bulge, which involves an increase in the passage section of the inlet diffuser and a decrease in the passage section of the inlet diffuser; the section decrease being arranged downstream of the section increase along the advancing direction. a flue-gases flowing chamber extending along a longitudinal axis and provided with an inlet and an outlet; a steam circuit fed with water and extending at least in part inside the flue-gases flowing chamber so as to exploit the heat of the flue-gases to generate steam; an inlet diffuser connected to the inlet of the flue-gases flowing chamber wherein flue-gases from a flue-gases source flow in one advancing direction; the heat recovery boiler being characterized by the fact that at least one first wall (22; 19; 20) of the inlet diffuser is provided with at least one first bulge, which involves an increase in the passage section of the inlet diffuser and a decrease in the passage section of the inlet diffuser; the section decrease being arranged downstream of the section increase along the advancing direction.
Medical infusion fluid heat exchange apparatus for warming medical infusion fluid, characterised in that the apparatus includes an elongate heat pipe of the kind containing a working fluid that operates using phase transition between a vapour and a liquid, a heat source mounted in thermal contact with one end of the heat pipe and an infusion fluid flow path extending along and around the outside of the heat pipe in thermal contact with the heat pipe, and that the heat source transfers heat to the heat pipe and the heat pipe transfers heat to the fluid flowing along the flow path.
An antibody or an siRNA for use in the treatment of cancer in a patient, wherein said cancer is non-small cell lung carcinoma (NSCLC) and said patient is a mammal having a cancer that expresses a CD74-ROS polypeptide, wherein the CD74-ROS polypeptide is encoded by a nucleotide sequence that is at least 95% identical to a sequence selected from the group consisting of: a) a nucleotide sequence encoding a CD74-ROS polypeptide comprising the amino acid sequence of SEQ ID NO: 1; b) a nucleotide sequence encoding a CD74-ROS fusion polypeptide, said nucleotide sequence comprising the nucleotide sequence of SEQ ID NO: 2; c) a nucleotide sequence encoding a CD74-ROS fusion polypeptide comprising the N-terminal amino acid sequence of CD74 (residues 1-208 of SEQ ID NO: 3) and the kinase domain of ROS (residues 1945-2222 of SEQ ID NO: 5); and d) a nucleotide sequence comprising the N-terminal nucleotide sequence of CD74 (nucleotides 1-624 of SEQ ID NO: 4) and the kinase domain nucleotide sequence of ROS (nucleotides 6032-6865 of SEQ ID NO: 6), and wherein the antibody or siRNA inhibits the expression or ROS kinase activity of the polypeptide. a) a nucleotide sequence encoding a CD74-ROS polypeptide comprising the amino acid sequence of SEQ ID NO: 1; b) a nucleotide sequence encoding a CD74-ROS fusion polypeptide, said nucleotide sequence comprising the nucleotide sequence of SEQ ID NO: 2; c) a nucleotide sequence encoding a CD74-ROS fusion polypeptide comprising the N-terminal amino acid sequence of CD74 (residues 1-208 of SEQ ID NO: 3) and the kinase domain of ROS (residues 1945-2222 of SEQ ID NO: 5); and d) a nucleotide sequence comprising the N-terminal nucleotide sequence of CD74 (nucleotides 1-624 of SEQ ID NO: 4) and the kinase domain nucleotide sequence of ROS (nucleotides 6032-6865 of SEQ ID NO: 6),
A support apparatus that can be mounted on the pelvic bone to support a support end of a proximal telescoping part of a distraction marrow nail that can be implanted with a distal anchoring part into a femur, comprising - a base plate that can be affixed to the pelvic bone, and - an accommodating device that is provided on a side of the base plate facing away from the pelvic bone for movably accommodating the support end of the telescoping part, characterized in that - the accommodating device comprises a ball seat having a cavity that forms a ball seat surface for accommodating a ball provided at the support end of the telescoping part, wherein the inside radius of the ball seat surface corresponds to the outside radius of the ball to be accommodated, wherein the ball seat comprises a base having a sub-cavity with a first partial ball seat surface, which is configured and disposed in such a manner that the ball can be freely laid into the sub-cavity, and comprises a covering having a second partial ball seat surface, which can be affixed in such a manner that the first partial ball seat surface makes a transition into the second partial ball seat surface to form a total ball seat surface, wherein the total ball seat surface is larger than the external hemispherical surface of the ball, and - the base plate is flattened at its proximal edge. - a base plate that can be affixed to the pelvic bone, and - an accommodating device that is provided on a side of the base plate facing away from the pelvic bone for movably accommodating the support end of the telescoping part, - the accommodating device comprises a ball seat having a cavity that forms a ball seat surface for accommodating a ball provided at the support end of the telescoping part, wherein the inside radius of the ball seat surface corresponds to the outside radius of the ball to be accommodated, wherein the ball seat comprises a base having a sub-cavity with a first partial ball seat surface, which is configured and disposed in such a manner that the ball can be freely laid into the sub-cavity, and comprises a covering having a second partial ball seat surface, which can be affixed in such a manner that the first partial ball seat surface makes a transition into the second partial ball seat surface to form a total ball seat surface, wherein the total ball seat surface is larger than the external hemispherical surface of the ball, and - the base plate is flattened at its proximal edge.
A pneumatic extraction device, characterized in that the pneumatic extraction device comprises: a holding group having a handle having at least one connecting arm transversally formed on and protruded from an external surface of the handle; and an outer shell connected to an end of the at least one connecting arm opposite to the handle such that the outer shell and the handle are spaced apart from each other at an interval by the at least one connecting arm; an air intake group connected to the holding group and having a connecting sleeve connected to the handle; and a vibration group connected to the holding group and the air intake group and having a main shaft connected to the connecting sleeve and being opposite to the handle, extended into the outer shell, and having a fixing head disposed on a bottom end of the main shaft; and a vibrating cylinder slidably mounted around the main shaft, mounted in the outer shell, and having an outer external surface non-contacted with an internal surface of the outer shell. a holding group having a handle having at least one connecting arm transversally formed on and protruded from an external surface of the handle; and an outer shell connected to an end of the at least one connecting arm opposite to the handle such that the outer shell and the handle are spaced apart from each other at an interval by the at least one connecting arm; a handle having at least one connecting arm transversally formed on and protruded from an external surface of the handle; and an outer shell connected to an end of the at least one connecting arm opposite to the handle such that the outer shell and the handle are spaced apart from each other at an interval by the at least one connecting arm; an air intake group connected to the holding group and having a connecting sleeve connected to the handle; and a vibration group connected to the holding group and the air intake group and having a main shaft connected to the connecting sleeve and being opposite to the handle, extended into the outer shell, and having a fixing head disposed on a bottom end of the main shaft; and a vibrating cylinder slidably mounted around the main shaft, mounted in the outer shell, and having an outer external surface non-contacted with an internal surface of the outer shell. a main shaft connected to the connecting sleeve and being opposite to the handle, extended into the outer shell, and having a fixing head disposed on a bottom end of the main shaft; and a vibrating cylinder slidably mounted around the main shaft, mounted in the outer shell, and having an outer external surface non-contacted with an internal surface of the outer shell.
A surgical staple (200, 300), comprising: a backspan (220, 320); a first leg member (230, 330) extending from the backspan (220, 320); a second leg member (240, 340) extending from the backspan (220, 330); and at least one substantially continuous channel (210, 310) extending along at least one of an inner surface and an outer surface of the first leg member (230, 330) and the second leg member (240, 340), characterised in that a transverse cross-section of each leg member includes a length and a height, the height defined by the distance between the wall having the channel (210, 310) and an opposing wall, and the length being greater than the height, and wherein said continuous channel (210, 310) extends along the backspan (220,320). a backspan (220, 320); a first leg member (230, 330) extending from the backspan (220, 320); a second leg member (240, 340) extending from the backspan (220, 330); and at least one substantially continuous channel (210, 310) extending along at least one of an inner surface and an outer surface of the first leg member (230, 330) and the second leg member (240, 340), characterised in that a transverse cross-section of each leg member includes a length and a height, the height defined by the distance between the wall having the channel (210, 310) and an opposing wall, and the length being greater than the height, and wherein said continuous channel (210, 310) extends along the backspan (220,320).
A distance weapon for non-lethal exposure of the human or animal body to irritant, comprising a housing (2, 4) containing at least an irritant, a propellant and moreover at least a medical adhesive, namely a cyanoacrylate preparation, polyvinylpyrrolidone or cellulose nitrate, characterised in that the irritant is 2-chlorobenzylidene malonic acid dinitrile CS, ω-chloroacetophenone CN or capsaicin CPS, wherein the distance weapon being configured as an irritant cartridge and the housing (2, 4) as a cartridge case closed by a plug which cartridge case contains the adhesive in liquid form, and wherein a fully closed adhesive chamber being accommodated in the housing (2,4) containing the adhesive which adhesive chamber is configured in the plug closing the cartridge case, and wherein the plug being a cylindrical inner case pressed into the cartridge case with an internal and external transverse wall (9, 10) which form the adhesive chamber, and wherein the cylindrical inner case of the plug extending beyond the internal transverse wall (9, 10) towards the inside to the bottom of the cartridge case, with the support formed as a result on the side of the internal transverse wall (9, 10) facing the bottom being filled with the irritant.
A computer-implemented method of lens shading color correction, the method comprising: obtaining at least one statistics grid of pixel data spatially corresponding to an input frame having blocks; selecting at least some of the blocks to be included in at least one cluster of blocks, the selecting including choosing candidate blocks at least with a difference in at least one of luminance or color ratio between (a) respective ones of the candidate blocks and (b) a reference block that meets at least one criteria; and finding an error associated with the color in the cluster; characterized by further comprising: using the errors associated with the clusters to determine respective weights for one or more lens shading correction tables; and combining the LSC tables based on the weights to form a composite LSC table to be applied to correct color at the frame. obtaining at least one statistics grid of pixel data spatially corresponding to an input frame having blocks; selecting at least some of the blocks to be included in at least one cluster of blocks, the selecting including choosing candidate blocks at least with a difference in at least one of luminance or color ratio between (a) respective ones of the candidate blocks and (b) a reference block that meets at least one criteria; and finding an error associated with the color in the cluster; characterized by further comprising: using the errors associated with the clusters to determine respective weights for one or more lens shading correction tables; and combining the LSC tables based on the weights to form a composite LSC table to be applied to correct color at the frame. using the errors associated with the clusters to determine respective weights for one or more lens shading correction tables; and combining the LSC tables based on the weights to form a composite LSC table to be applied to correct color at the frame.
A coffee machine having a brewing unit having a terminal for production of the beverage, and a device for the preparation of a dose of ground coffee powder comprising a filter holder cup having a filter for the introduction and collection of said dose of ground coffee powder, an attaching support to which said filter holder cup is separably attached and a grinder for coffee beans comprising a slide for dispensing ground coffee having an outlet positioned above said filter of said filter holder cup, wherein said device comprises a pressing piston of said dose of ground coffee powder present in said filter holder cup, a lifting mechanism of said pressing piston in a position above said outlet of said slide, said pressing piston being rigidly supported by a vertical stem which extends above it, said lifting mechanism comprising a manual rotating control element being either a lever or a knob and a transmission which transforms the rotation of said manual rotating control element in a vertical translation of said pressing piston, the coffee machine being characterized in that the transmission of said lifting mechanism comprises a gear comprising a vertical rack solidly constrained to said stem and an arch of a cogwheel supported by a horizontal mechanical axis connected to said control element, and in that the coffee machine further comprises pressing force adjustment means comprising an elastic clutch which connects two elements of said lifting mechanism to each other, said two elements connected by said elastic clutch being said control element and said arch of a cogwheel.
An aqueous gelling agent composition, comprising: Compound represented by the following general formula; and Compound represented by the following general formula, wherein a mass ratio of compound to compound,:, is from 95:5 to 85:15: where R 1, R 2, R 8, and R 9 each independently represent a hydrocarbon group having 4 to 20 carbon atoms, R 3, R 5, and R 7 each independently represent a divalent hydrocarbon group having 2 to 4 carbon atoms, R 4 and R 6 each independently represent a divalent hydrocarbon group having 3 to 16 carbon atoms, a and e each independently represent a number of 10 to 100, d represents a number of 100 to 500, and g represents a number of 1 to 10; and where R 10, R 11, R 15, and R 16 each independently represent a hydrocarbon group having 4 to 20 carbon atoms, R 12 and R 14 each independently represent a divalent hydrocarbon group having 2 to 4 carbon atoms, R 13 represents a divalent hydrocarbon group having 3 to 16 carbon atoms, and j and m each independently represent a number of 10 to 100. Compound represented by the following general formula; and Compound represented by the following general formula, wherein a mass ratio of compound to compound,:, is from 95:5 to 85:15: where R 1, R 2, R 8, and R 9 each independently represent a hydrocarbon group having 4 to 20 carbon atoms, R 3, R 5, and R 7 each independently represent a divalent hydrocarbon group having 2 to 4 carbon atoms, R 4 and R 6 each independently represent a divalent hydrocarbon group having 3 to 16 carbon atoms, a and e each independently represent a number of 10 to 100, d represents a number of 100 to 500, and g represents a number of 1 to 10; and where R 10, R 11, R 15, and R 16 each independently represent a hydrocarbon group having 4 to 20 carbon atoms, R 12 and R 14 each independently represent a divalent hydrocarbon group having 2 to 4 carbon atoms, R 13 represents a divalent hydrocarbon group having 3 to 16 carbon atoms, and j and m each independently represent a number of 10 to 100.
A process for producing a food product comprising either supplementing a food with, or supplementing a component of a food with, a phytochemical fraction recovered from a crude caffeine, whereby said food product is produced; wherein said phytochemical fraction has a ratio of polyphenols to caffeine of about 10 - 40 to 1, wherein said phytochemical fraction is a retentate of a filtration process of a water suspension of crude caffeine, and wherein said crude caffeine is a product of a green coffee bean supercritical carbon dioxide (scCO 2) decaffeination process.